RecallDepth
Class II Terminated

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

This recall has been terminated (originally issued February 22, 2017).

Company
Actavis Inc
Recall Initiated
January 30, 2017
Posted
February 22, 2017
Recall Number
D-0476-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
499320 units
Firm Location
Parsippany, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

Distribution

Nationwide in US

Lot / Code Info

Lot #: 3134201, 3134202, Exp. 06/30/17; 3134319, Exp. 05/31/17; 3135246, Exp. 07/31/17; 3135247, 3136781, Exp. 08/31/17; 3136782, Exp. 09/30/17; 3136903, 3136904, Exp.10/31/17; 3138250, Exp. 07/31/17; 3138968, Exp. 08/31/17; 3140000, Exp. 09/30/17

More recalls by Actavis Inc

View all recalls by this company →

Other recent Class II Drug recalls